AFP and hepatocellular carcinoma: (53) created a model that predicts how unresectable hepatocellular carcinoma (HCC) will react to transarterial chemoembolization in conjunction with molecular targeted therapy and immunotherapy by combining preoperative multi-parametric magnetic resonance imaging (MRI) radiomics features with clinical features (alpha-fetoprotein and neutrophil-to-lymphocyte ratio).